S61 Role of Prolactin in Health and Disease

Program: Symposia
Basic/Translational Session
Sunday, April 3, 2016: 4:45 PM-6:15 PM
Room 156 (BCEC)
Charles V. Clevenger, MD, PhD, Virginia Commonwealth University, Richmond, VA

Nothing to Disclose: CVC
4:45 PM
Vincent Goffin, PhD, Inserm U1151 - Institut Necker Enfants Malades (INEM), Faculté de Médecine, Université Paris Descartes, Paris, France
Nothing to Disclose: VG
5:15 PM
Nadine Binart, PhD, University Paris-Saclay, Inserm U1185, Le Kremlin-Bicêtre, France
Nothing to Disclose: NB
5:45 PM
Ingrid Struman, PhD, Interdisciplinary Cluster in Applied Genoproteomics (GIGA) Research Center, University of Liège, Liege, Belgium
Nothing to Disclose: IS
See more of: Symposia


The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire